# IOVANCE BIOTHERAPEUTICS, INC. (IOVA) FY2026 Q2 P&L / Income Statement

- Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001104659-26-091716
- Page: https://plicit.ai/financials/iova/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/iova-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 99,313,000 US dollars
- **Cost of sales**: 43,595,000 US dollars
- **Gross profit (calculated)**: 55,718,000 US dollars
- **Operating expenses (calculated)**: 107,623,000 US dollars
- **Loss from operations**: negative 51,905,000 US dollars
- **Other income (expense), net (calculated)**: 3,217,000 US dollars
- **Net Loss before income taxes**: negative 48,688,000 US dollars
- **Income tax benefit (expense)**: negative 1,373,000 US dollars
- **Net Loss**: negative 47,315,000 US dollars
- **Amtagvi**: 90,721,000 US dollars
- **Proleukin**: 8,592,000 US dollars
- **Research and development**: 58,851,000 US dollars
- **Selling, general, and administrative**: 39,272,000 US dollars
- **Depreciation and amortization**: 9,500,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/iova/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/iova-fy2026-q2-revenue-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 99,313,000 US dollars
- **Cost of sales**: 43,595,000 US dollars
- **Gross profit (calculated)**: 55,718,000 US dollars
- **Operating expenses (calculated)**: 107,623,000 US dollars
- **Loss from operations**: negative 51,905,000 US dollars
- **Other income (expense), net (calculated)**: 3,217,000 US dollars
- **Net Loss before income taxes**: negative 48,688,000 US dollars
- **Income tax benefit (expense)**: negative 1,373,000 US dollars
- **Net Loss**: negative 47,315,000 US dollars
- **UNITED STATES**: 98,967,000 US dollars
- **Rest of world**: 346,000 US dollars
- **Research and development**: 58,851,000 US dollars
- **Selling, general, and administrative**: 39,272,000 US dollars
- **Depreciation and amortization**: 9,500,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.